预测接受调强放疗的头颈癌患者急性放射性皮炎评分系统
本研究纳入2013至2017年在本院接受根治性调强放疗或容积旋转调强放疗、处方剂量70 Gy的头颈癌患者101例,比较1-2级与3级皮炎患者体轮廓内5 mm处的皮肤V5Gy至V60Gy剂量体积参数,基于逻辑回归分析建立包含V60Gy、同步化疗状态、年龄和体重指数的评分系统,递归分割分析将患者分为0-1、2-3和4-6分三个亚组,3级皮炎发生率分别为0%、20.5%和58.6%(P<0.01)。
要点
- V60Gy在逻辑回归和递归分割分析中均与放射性皮炎分级显著相关。
- 评分系统纳入V60Gy、同步化疗状态、年龄和体重指数,将患者分为0-1、2-3、4-6分三个亚组。
- 3级皮炎发生率在三个亚组分别为0%、20.5%和58.6%(P<0.01)。
核心结论
- 纳入剂量体积参数的风险分析模型成功预测了急性皮肤反应,将有助于放射性皮炎的正确管理。
研究设计与样本
- 本研究为单中心连续纳入101例2013至2017年在本院接受根治性调强放疗或容积旋转调强放疗、处方剂量70 Gy的头颈癌患者的分析。
- 比较1-2级与3级皮炎患者体轮廓内5 mm处的皮肤V5Gy、V10Gy、V20Gy、V30Gy、V40Gy、V50Gy和V60Gy值。
- 基于逻辑回归分析识别最显著的剂量学和临床因素,建立评分系统,并用递归分割分析将患者分为三个亚组。
主要发现
- V60Gy在逻辑回归分析和递归分割分析中均与放射性皮炎分级显著相关。
- 评分系统纳入V60Gy、同步化疗状态、年龄和体重指数,递归分割分析将全部患者分为0-1分、2-3分和4-6分三个亚组。
- 3级皮炎发生率在0-1分、2-3分和4-6分亚组分别为0%、20.5%和58.6%(P<0.01),亚组间差异显著。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: We created a scoring system incorporating dosimetric and clinical factors to assess the risk of severe, acute skin reactions in patients undergoing intensity-modulated radiation therapy (IMRT) to treat head and neck cancer (HNC). MATERIALS AND METHODS: A total of 101 consecutive patients who received definitive IMRT or volumetric modulated arc therapy (VMAT) with a prescription dose of 70 Gy to treat HNC between 2013 and 2017 in our hospital were enrolled. Skin V5Gy, V10Gy, V20Gy, V30Gy, V40Gy, V50Gy, and V60Gy values delivered 5 mm within the body contour were compared between patients with Grades 1-2 and Grade 3 dermatitis. A scoring system was created based on logistic regression analysis (LRA) that identified the most significant dosimetric and clinical factors. RESULTS: The V60Gy was significantly associated with radiation dermatitis grade in both LRA and recursive partitioning analysis (RPA). A scoring system incorporating the V60Gy, concurrent chemotherapy status, age, and body mass index was used to divide all patients into three subgroups (0-1, 2-3, and 4-6 points) in the RPA. The incidence of Grade 3 dermatitis significantly differed among the subgroups (0, 20.5, and 58.6%, respectively, P < 0.01). CONCLUSIONS: A risk analysis model incorporating dose-volume parameters successfully predicted acute skin reactions and will aid in the appropriate management of radiation dermatitis.
引用
- Kawamura M, Yoshimura M, Asada H, et al. A scoring system predicting acute radiation dermatitis in patients with head and neck cancer treated with intensity-modulated radiotherapy. Radiat Oncol. 2019. PMID: 30665451. doi:10.1186/s13014-019-1215-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。